$0.4532
0.07921.11%
Last update: Nov 11, 11:13 AM
Tempest Therapeutics Inc
TPSTNASDAQ
Tempest Therapeutics fell 96.2% from $9.62 to $0.36, behind the S&P 500's +9.8%. Its worst day was Nov 19 (−48.6%), and its low came Nov 9 at $0.36.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Tempest Therapeutics shares fell 48.6%, while the S&P 500 rose 0.4%.
−48.6%, the year's worst day · S&P 500 +0.4%
Story events cover the past 12 months · Times ET
EPS of $-0.62 beat the $-0.62 estimate on $0.00 revenue.
−12.1% · S&P 500 −0.3%
Tempest Therapeutics shares rose 29.7%, while the S&P 500 fell 0.1%.
+29.7% · S&P 500 −0.1%
EPS of $-0.50 missed the $-0.28 estimate on $0.00 revenue.
−12.4% · S&P 500 −1.2%
EPS of $-0.34 missed the $-0.30 estimate on $0.00 revenue.
−13.2% · S&P 500 −0.2%
Tempest Therapeutics shares rose 60.2%, while the S&P 500 fell 0.4%.
+60.2%, the year's best day, on 105M shares, the year's heaviest volume · S&P 500 −0.4%
Where it ended: a close of $0.36 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.32).
Nothing in the past 12 months.
All TPST dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TPST and SPY from Benzinga historical bars. Not investment advice.
